Mouse G258 mutant stopped both cell growth and the synthesis of lipid-linked oligosaccharide at the Man 3 GlcNAc 2 -P-P-Dolichol at a restricted temperature with a single gene mutation. To clarify the lesion in the G258 mutant, we isolated human genomic DNA transformants of the G258 mutant, which recovered from both defects by way of cell hybridization with X-ray irradiated HeLa cells. We detected a common 1.3-kb product by inter-human specific sequence in the L1 (L1Hs) PCR in the transformants (Kataoka et al., Somat. Cell Mol. Genet., 24, 235-243 (1998)). In the present study, we screened a human mega yeast artificial chromosome (YAC) library by PCR with primers designed according to the 1.3-kb DNA, and selected YAC clone 923f5. Moreover, we found by spheroplast fusion that YAC clone 923f5 complemented both defects of the G258 mutant. Since the human counterpart of the yeast ALG11 gene is localized in the region, the G258 mutant might have a defect in the mouse ALG11 gene.
The lipid-linked oligosaccharide Glc 3 Man 9 GlcNAc 2 -P-P-Dol serves as a precursor in the biosynthesis of the asparagine-linked oligosaccharide of glycoprotein. The biosynthesis of lipid-linked oligosaccharide is highly conserved among eukaryotes and is carried out by 14 glycosyltransferases in an ordered stepwise manner. The first half of the assembly is done in the cytoplasmic face of the rough ER membrane by glycosyltransferases, using UDP-GlcNAc and GDP-Man as donors. The latter half is done in the luminal face of the rough ER membrane by glycosyltransferases, using Dol-P-Man and Dol-P-Glc as donors. 1) Since it is difficult to obtain acceptor for each enzyme, genetic studies have been performed to elucidate the process. Mutants that have a defect in these steps have been isolated in yeast mainly as temperature-sensitive mutants, by the tritium-suicide method and the synthetic lethal method.
1) The respective genes were isolated mainly in yeast by complementation of mutants in cell growth, and later in mammals by homology cloning. 1) Until recently, the gene for two steps of the 14 steps in the synthesis of the lipid-linked oligosaccharides (the mannosyltransferase II gene and the mannosyltransferase IV gene) remained to be clarified for a long time, but in 2006, Imperiali's group 2) found that the ALG2 protein (originally attributed to mannosyltransferase III) and the ALG11 protein (originally attributed to mannosyltransferase V) have dual functions. The ALG2 protein has both mannosyltransferase II and mannosyltransferase III activities, and the ALG11 protein has both mannosyltransferase IV and mannosyltransferase V activities. Thus all the genes involved in the 14 steps in the synthesis of the lipid-linked oligosaccharide were elucidated.
We have been attempting to isolate the human and mouse genes encoding the GDP-mannose dependent mannosyltransferase involved in the first half of the lipid-linked oligosaccharide synthesis in the cytoplasmic face of the rough ER membrane by expressional cloning 3) and homology cloning. 4, 5) As for the expression cloning approach, previously we isolated temperature-sensitive asparagine-linked glycosylation mutant G258 from the FM3A mouse mammary carcinoma cell line by [2- 3 H] mannose suicide selection. The G258 mutant has temperature sensitivities in both cell growth and asparagine-linked glycosylation 6) due to a single gene mutation at a step in the synthesis of the lipid-linked oligosaccharide. 7) Since the G258 mutant can synthesize the full-sized lipid-linked oligosaccharide (Glc 3 Man 9 GlcNAc 2 -P-PDol) at 33 C but at 39 C, the mutant cells cannot elongate the lipid-linked oligosaccharide beyond Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-PDol. Therefore the defect in the G258 mutant might reside in the activity or the expression of GDPMan:Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-P-Dol 1,2-mannosyltransferase (mannosyltransferase IV) activity. 3, 6, 7) Since both temperature sensitivities were due to a single gene mutation, a cDNA or a genomic DNA fragment that can complement the y To whom correspondence should be addressed. Present address: 2-18-7 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan; Tel/Fax: +81-3-5689-2764; E-mail: yoshi.nishikawa@hop.ocn.ne.jp Abbreviations: Dol, Dolichol; FBS, fetal bovine serum; ER, endoplasmic reticulum; YAC, yeast artificial chromosome; L1Hs, human specific sequence in the L1 temperature sensitivity in cell growth of G258 mutant cells might contain the mannosyltransferase IV gene (putatively designated mat-4).
6,7)
Hence we attempted to isolate the human mannosyltransferase IV gene, Hmat-4, that complements the temperature sensitivity of lipid-linked oligosaccharide synthesis of G258 mutant cells by combining the expression cloning and the positional cloning approach. As described in a previous report, 3) we isolated the human genomic DNA transformants of the G258 mutant for several reasons: (i) The population of cDNAs encoding the proteins involved in lipid-linked oligosaccharide synthesis in the cDNA libraries is very low, and the gene expression involved in lipid-linked oligosaccharide synthesis is low in yeast and mammalian cells [8] [9] [10] [11] [12] (ii) The G258 mutant shows very low efficiency of transfection by ordinary methods such as calcium phosphate-DNA co-precipitation, electroporation, and lipofection. Even on transfection of a selectable marker (G418 resistance), the efficiency of transfection was found to be less than 1 Â 10 4 (unpublished data). (iii) However, it is likely that the population of genomic DNAs encoding proteins involved in lipidlinked oligosaccharide synthesis is similar to those of genomic DNAs encoding most other proteins. In a previous study, 3) we isolated human genomic DNA fragment transformants of the G258 mutant by the radiation hybrid method using X-ray-irradiated HeLa cells. The resulting transformants (KK-1, KK-3, and KK-4) showed recovery from both temperature-sensitive growth and temperature-sensitive asparagine-linked glycosylation. Moreover, we detected a common 1.3-kb inter-L1Hs PCR sequence in the transformants and determined the nucleotide sequence of the 1.3-kb interL1Hs PCR product of the KK-3 cells. That sequence contained 1,279 bases, including one Alu sequence, one (GT) 21 repeated sequence, and one Xba I site. Moreover, we detected a unique sequence containing about 700 bp in the 1.3-kb sequence (Fig. 1) . The 1.3-kb sequence presumably localizes near the gene that complements the temperature-sensitive defects in both cell growth and lipid-linked oligosaccharide synthesis in the G258 mutant, and can be used as a marker DNA to isolate the Hmat-4 gene. 3) In the present study, by PCR using primers based on the unique sequence in the 1.3-kb sequence, we found a human mega YAC clone 923f5 that contains the 1.3-kb sequence, and found that the YAC clone 923f5 complemented the defects of G258 mutant.
Materials and Methods
Cell lines and culture. C3H/He mouse mammary carcinoma cell line FM3A clone F28-7 13) and its temperature-sensitive mutant G258, 3, 6, 7) which is defective in the synthesis of lipid-linked oligosaccharides, were routinely maintained at 33 C in RPMI1640 medium (RPMI1640 no. 2, Nissui, Tokyo) supplemented with 5% heatinactivated fetal bovine serum (FBS), streptomycin (40 mg/mL), and penicillin G (40 U/mL). Candidate YAC clone 923f5 transformants of the G258 mutant were routinely maintained at 39 C (the restrictive temperature for G258 mutants) in the same medium. A mouse A9-human monochromosome 1 hybrid cell line (JCRB2201) and a mouse A9-human monochromosome 13 hybrid cell line (JCRB2213) were purchased from the Japanese Collection of Research Bioresources (JCRB, Sennan, Osaka, Japan), and were grown in the Dulbecco's Modified MEM (DMEM) containing 10% FBS and 1 mg/mL of hygromycin B at 37 C. Mammalian cells were grown in a humidified 5% CO 2 atmosphere in a CO 2 incubator. Cell viability was measured by trypan blue exclusion.
Yeast cells harboring human mega YAC clone 923f5 were obtained from CEPH (Paris, France), and were grown at 30 C in SD URA À TRP À medium (Funakoshi, Tokyo).
YAC library screening. Human mega YAC libraries (CEPH, Paris, France) were screened by a PCR-based method using LPP1-2F and LPP1-4R primers designed on the basis of a unique sequence in the 1.3-kb sequence: 7) LPP1-2F (5 0 -GCCCAAGTCAAAATACTAG-CAGG-3 0 ), LPP1-4R (5 0 -TTGAGGTATAACATAGATGGTAAG-3 0 ) (Greiner Japan, Tokyo). All PCR amplifications were done using 50 ng of template DNA in a reaction volume of 50 mL including 10 mM TrisHCl pH 8. Transformation of the G258 mutant with YAC clone 923f5. Spheroplast fusion was done by the method of Blunt et al. 14) Yeast cells harboring YAC clone 923f5 were grown in SD URA À TRP À medium to late log phase (about 2 Â 10 7 cells/mL) and then diluted with the medium to two-thirds and grown through two doubling cycles at 30 C. The yeast cells (total, 1 Â 10 8 cells) were harvested, washed twice with 1 M sorbitol, and suspended in 5 mL of 1 M sorbitol-0.1 M sodium citrate-10 mM EDTA-30 mM 2-mercaptoethanol, pH 5.8 (SCE). Then 25 mL of Zymolyase (Seikagaku Kogyo, Tokyo, 20 mg/mL in SCE) was added to the suspension with gentle stirring. The suspension was incubated at 30 C until 90% of the cells formed spheroplasts as determined by lysis in 5% SDS. The spheroplasts were harvested by centrifugation at 4 C at 1,200 rpm for 7 min, washed twice with 5 mL of 1 M sorbitol-10 mM Tris-HCl, pH 7.5 (ST), and suspended with 500 mL of ice-cold ST on ice. The suspension was added to G258 cells (total, 1 Â 10 7 cells) suspended in serum-free RPMI1640 medium. The mixed cells were harvested by centrifugation at 1,200 rpm for 3 min at room temperature, resuspended in 0.5 mL of 50% polyethyleneglycol 1500, and allowed to fuse for 1 min at 37 C. Then the suspension was carefully diluted 2-fold with RPMI1640 + 5% FBS several times. The diluted cell mixtures were centrifuged at 800 rpm for 5 min at room temperature. The precipitates were suspended in 10 mL of RPMI1640 medium supplemented with 5% heat-inactivated FBS, streptomycin (40 mg/mL), and penicillin G (40 U/mL), and were grown at 33 C for 3 d to allow them to express the genes of the YAC clone 923f5 in the YAC transformant. Then about 1 Â 10 5 cells were plated on each of several soft agar plates, and the plates were incubated at 39 C for 2 weeks. The surviving colonies were removed with toothpicks and streaked on the soft agar plates. The plates were incubated at 39 C for further 2 weeks. Single colony isolation was repeated 3 times. Randomly selected YAC clone 923f5 transformants (GYS-1, -2, -14, -17, -20, and -25) were maintained at 39 C throughout the study. The isolates were checked for the presence of the 1.3-kb DNA sequence by PCR. Five out of the 6 candidate transformants showed the 1.3-kb DNA sequence throughout the study, as explained below under ''Results.'' PCR analysis of DNAs from mouse A9-human monochromosome hybrid cell lines and the YAC clone 923f5 transformants of the G258 mutant. DNAs from mouse A9-human monochromosome hybrid cell lines (JCRB2201, a mouse A9-human monochromosome 1 hybrid cell line, and JCRB2213, a mouse A9-human monochromosome 13 hybrid cell line), and candidate YAC clone 923f5 transformants of G258 mutant were prepared as previously described.
15) The presence of the 1.3-kb DNA in the DNAs of JCRB2201 and JCRB2213 was analyzed by PCR using the LPP1-2F primer and the LPP1-4R primer, as described above. For the analysis of the 1.3-kb DNA in the DNAs of the YAC clone 923f5 transformants of the G258 mutant, the PCR products (551 bp), using the LPP1-2F primer and the LPP1-4R primer, were digested with Xba I. The Xba I digestion yielded both the 439-bp and the 112-bp fragments. Only the 439-bp fragment was detected on agarose gel electrophoresis.
Colony formation on soft agar plates. In soft agar culture, appropriately diluted cells were plated on RPMI1640 soft agar plates containing 0.5% Difco Agar Noble (Becton-Dickinson, Franklin Lakes, NJ), 5% heat-inactivated FBS, streptomycin (40 mg/mL), and penicillin (40 U/mL). The plates were incubated at 33 C and 39 C in a CO 2 incubator.
Asparagine-linked glycosylation. The asparagine-linked glycosylation of FM3A cells, G258 mutants, and some candidate YAC clone 923f5 transformants of the G258 mutant was measured as previously described. 3, 6, 7) Protein determination. Protein was assayed by the method of Lowry et al., 16) using bovine serum albumin (BSA) as standard.
Radioisotopes. D-[2-
3 H] mannose (1 mCi/mL in 50% ethanol) was purchased from Moravec Biochemicals (La Brea, CA).
YAC end isolation and analysis. Five mL of exponentially grown YAC clone 923f5 was harvested, suspended in 5 mL of SCE, and treated with Zymolyase (0.2 mg/mL) for 30 to 60 min at 30 C. DNA was purified from the lysate as previously described. 17) The right end of YAC clone 923f5 was amplified from YAC clone 923f5 DNA by PCR by the Expand Long Template PCR System (Roche Diagnostics, Tokyo). PCR was done from 30 ng of YAC clone 923f5 genomic DNA in a reaction volume of 100 mL including
containing the HindIII site, underlined) and 0.3 mM Alu primer 278 (5 0 -CCGAATTCGCCTCCCAAAGTGCTGGGATTACAG-3 0 containing the EcoRI site, underlined) (Greiner Japan, Tokyo). The reaction was carried out through 30 cycles of 94 C for 1 min (denaturation), 60 C for 45 s (annealing), and 72 C for 1 min (elongation) in the thermal cycler. The PCR product was isolated by agarose gel electrophoresis, and was purified with a High Pure PCR Product Purification Kit (Roche Diagnostics, Tokyo). The purified PCR product was ligated with Sma I-digested pUC118 vector at 16 C overnight using Ligation Kit Ver. 2 (Takara, Kyoto, Japan). The ligated construct was transfected to competent JM109. The transformants were plated on LB agar containing ampicillin (50 mg/mL), X-Gal, and IPTG. The transformants forming white colonies were isolated, and their DNAs were prepared as previously described.
15) The size of their integrated DNA was confirmed by agarose gel electrophoresis after PvuII digestion. The resulting right end of YAC clone 923f5 was sequenced by a method described elsewhere. 3) Database search. The Entrez Nucleotides database (http://www.ncbi/ nlm/nih.gov/entrez/query) was used to obtain the nucleotide sequences of the cloned glycosyltransferases. A BLAST search was done using both NCBI (http://www.ncbi.nlm.nih.gov/BLAST/index.shtml) and DDBJ/ EMBL/GenBank databases (http://blast.ddbj.nig.ac.jp/top-e.html). The Ensembl Genome Browser (http://www.sanger.ac.uk/resources/databases/ ensembl.html) was used to obtain a BAC contig map of YAC clone 923f5.
Results
The human mega YAC clone 923f5 contained the 1.3-kb sequence
We designed PCR primers (LPP1-2F and LPP1-4R, see ''Materials and Methods'') based on a unique sequence within the 1.3-kb sequence (Fig. 1) , 3) and screened a human mega YAC library by PCR with these primers. We detected six positive YAC clones, 616e2, 628c3, 682f3, 816e1, 879f4, and 923f5, yielding approximately 551-bp PCR product (data not shown).
Among these, we analyzed two clones whose originated chromosomes were known at the time: YAC clone 879f4 originated from the chromosome 1 and YAC clone 923f5 (1.06 Mb) from the chromosome 13 region q14.3. Hence we did PCR analysis using LPP1-2F and LPP1-4R PCR primers on DNAs from mouse A9-human monochromosome hybrid cell lines (JCRB2201, containing human chromosome 1, and JCRB2213, containing human chromosome 13). In the control experiment, we detected the 551 bp PCR product not in the DNAs of the mouse G258 mutant cells, but those of human HeLa cells. Thus, we detected the 551-bp PCR product using cellular DNA not from a mouse A9-human monochromosome 1 hybrid cell line, but from a mouse A9-human monochromosome 13 hybrid cell line (Fig. 2, lanes 2  and 3) . Moreover, the 551-bp PCR product on the cellular DNA was detected not in G258 mutant cells, but in HeLa cells (Fig. 2, lanes 4 and 5) . The 551-bp sequence corresponded to the estimated distance between the PCR primer sequences (Figs. 1 and 2 ). Hence we concluded that the human mega YAC clone 923f5 contains the 1.3-kb sequence.
Isolation of candidate YAC clone 923f5 transformants of the G258 mutant
The results described above suggest that the human gene, putatively designated Hmat-4 (human mannosyltransferase IV) at the time, that is expected to complement the defect in the G258 mutant, might also localize on human chromosome 13 region q14.3 in YAC clone 923f5 (1.06 Mb, 0.03% of the human genome in size). To test this possibility, we transfected the 1.06 Mb human genomic DNA fragment in the YAC clone 923f5 into G258 mutant cells by spheroplast fusion, and isolated candidate transformants (GYS strains) that showed recovery from temperature-sensitive growth, as described above in ''Materials and Methods.'' This method was based on the fact that the G258 mutant is temperature sensitive as to both cell growth and lipid intermediate synthesis, as well as asparagine-linked glycosylation, due to a single gene mutation.
7)
The efficiency of isolation of the transformants was 2:2$7:7 Â 10 À5 . On the other hand, yeast YPH501, which does not have human mega YAC genomic DNA, did not complement the defect in the G258 mutant under the same conditions. We obtained 28 candidate transformants. Among them, six candidates (GYS-1, -2, -14, -17, -20, and -25) were randomly selected and analyzed further.
Recovery of cell growth in the candidate YAC clone 923f5 transformants of the G258 mutant
Growth recovery was tested by both liquid culture and soft agar culture, as described in ''Materials and Methods.'' Growth and viability in the liquid culture at 33 C and 39 C are shown in Fig. 3 . The FM3A cells grew faster at 39 C than at 33 C (Fig. 3A a) and their viability decreased as they reached the stationary phase (Fig. 3B a) . At 33 C, the G258 mutants grew at a rate similar to the FM3A cells grown at that temperature. However, at 39 C, the growth of the G258 mutants stopped before reaching the maximum cell number achieved at 33 C (Fig. 3A b) . The viability of the G258 mutants decreased rapidly after a temperature shift to 39 C (Fig. 3B b) . On the other hand, all the candidate transformants (GYS-1, -2, -14, -17, -20, and -25) showed growth patterns in both growth curve and viability, similarly to the FM3A cells at both 33 C and 39 C (Fig. 3A c to h and Fig. 3B c to h ). Growth on soft agar plates at 33 C and 39 C is shown in Table 1 . The FM3A cells showed colony forming activity at 39 C similar to that at 33 C. The G258 mutant cells formed colonies at 33 C but not at 39 C. All the candidate transformants showed comparable efficiency of colony formation at 33 C and 39 C.
Recovery from temperature-sensitive asparaginelinked glycosylation in the candidate YAC clone 923f5 transformants
Of the candidate transformants, the GYS-1, -14, -17, and -20 cells were further analyzed for reversion of temperature-sensitive asparagine-linked glycosylation, as shown in Fig. 4 . The FM3A cells showed increased incorporation of [2- 3 H] mannose into the acid-insoluble fraction at 39 C as compared to 33 C (Fig. 4a) . The G258 mutants showed decreased incorporation of [2- 3 H] mannose into the acid-insoluble fraction at 39 C as compared to 33 C and to FM3A cells at both temperatures (Fig. 4b) . All the candidate YAC clone 923f5 transformants of the G258 mutants showed recovery of [2- 3 H] mannose incorporation at 39 C, although the levels of recovery were different among them (Fig. 4,  c to f) .
Occurrence of the 1.3-kb sequence in the candidate YAC clone 923f5 transformants of the G258 mutant cells Among the candidate YAC clone 923f5 transformants of the G258 mutant cells tested, GYS-1, -14, -17, and -20 showed reversion of both temperature-sensitive growth (Table 1) and asparagine-linked glycosylation (Fig. 4) . It was necessary to show the presence of the Ã average colony number at 39 C/average colony number at 33 C 1.3-kb sequence to confirm that they are the YAC clone 923f5 transformants of G258 mutant cells. Hence the occurrence of the 551-bp PCR product and the cleavability of the 551-bp PCR product by Xba I digestion were tested in these GYS strains (Fig. 5) . The G258 mutant DNA (negative control) did not yield the 551-bp PCR product (lanes 2 and 3) . On the other hand, HeLa DNA (positive control) yielded the 551-bp PCR product and its Xba I-digested 439-bp fragment (lanes 4 and 5). The DNAs from GYS-1, -14, -17, and -20 also yielded the 551-bp PCR product and its Xba I-digested 439-bp fragment (lanes 7, 8, 10 to 16). The DNAs from GYS-2 yielded a faint Xba I-sensitive 551-bp PCR product, but the DNAs from GYS-25 did not yield the Xba Isensitive 551-bp PCR product (lanes 9, 10, 17 and 18).
Identification of the YAC clone 923f5 transformants of the G258 mutant
The results of the present study are summarized in Table 2 . Judging from the reversion of both temperature-sensitive cell growth and temperature-sensitive asparagine-linked glycosylation and from the presence of the 1.3-kb sequence, we concluded that GYS-1, -14, -17, and -20 are genuine YAC clone 923f5 transformants of the G258 mutant. In other words, the YAC clone 923f5 complemented the defect of lipid-linked oligosaccharide synthesis in the G258 mutant.
YAC end isolation and analysis of it
To localize the 1.3-kb sequence in the YAC clone 923f5, we attempted to obtain both ends of the insert in YAC clone 923f5 by PCR using the sequence of the cloning sites of YAC vector YAC4 (YAC4R and YAC4L) and the Alu sequences. As a result, we succeeded in amplifying the right end of YAC clone 923f5 by PCR using YAC4R and the Alu primer (primers 278, 517, etc.). The PCR products showed the expected sizes based on the positions of the primers in the Alu sequence. The PCR product using the YAC4R and 278 primers was ligated with the pUC118 and sequenced. The entire human genomic DNA sequence in the PCR product was almost the same as the partial sequence (from A 36252 to G 36643 ) of BAC clone RP11-431O22 (AL139085), which appears in the human genomic DNA database (Fig. 6) . On the other hand, we found that BAC clone RP11-64P12 (AL158066) contained the 1.3-kb DNA. Based on the size of the human genomic DNA in YAC clone 923f5 (1.06 Mb), we made a BAC contig map of YAC clone 923f5. In addition, we found that the YAC clone 923f5 can complement the defect in the asparagine-linked glycosylation of G258 mutant. Hence we concluded that the Hmat-4 gene, originally defined as human mannosyltransferase IV gene, might reside in the human genomic DNA of YAC clone 923f5.
Discussion
Although yeast genetic studies were mainly performed to analyze the steps in the synthesis of lipidlinked oligosaccharides, mutants with defects in man- nosyltransferase II, mannosyltransferase VI, and mannosyltransferase V had not been isolated at the time we isolated the mouse G258 mutant, which has a temperature-sensitive defect in both the synthesis of lipidlinked oligosaccharide and cell growth due to a single gene mutation. The lesion in the G258 mutant appeared reside in the mannosyltransferase IV activity. Therefore the G258 mutant might be a useful tool for the study of mannosyltransferase IV. 3, 6, 7) Previously we isolated by the radiation hybrid method human genomic DNA transformants that recovered from temperature sensitivities in both cell growth and asparagine-linked glycosylation of the G258 mutants, and we detected a 1.3-kb DNA product due to interL1Hs PCR in most of the transformants.
In the present study, we attempted to use the 1.3-kb sequence as a marker DNA to isolate and characterize human gene Hmat-4, which complements the defect of lipid-linked oligosaccharide synthesis in the G258 mutant. Hence we screened a human mega YAC library by PCR using primers designed on the unique region in the 1.3-kb DNA sequence. We detected YAC clone 923f5 (1.06 Mb), which has human genomic DNA derived from human chromosome 13q14.3. By spheroplast fusion of YAC clone 923f5 with the G258 mutant, we isolated the YAC clone 923f5 transformants of the G258 mutant. The transformants showed recovery from the temperature-sensitive defects in both cell growth and asparagine-linked glycosylation shown by the G258 mutant (Figs. 3 and 4 , Tables 1 and 2) .
Moreover, among the tested transformants, GYS-1, -14, -17, and -20 showed the presence of the 1.3-kb DNA (Fig. 5, Table 2 ). These results suggest that the YAC clone 923f5 contains the gene that complements the defect in the synthesis of lipid-linked oligosaccharide of the G258 mutants. We concluded at the time that the Hmat-4 gene might reside in YAC clone 923f5, which has 1.06 Mb of human genomic DNA. It is worthy of note that complementation studies by spheroplast fusion have been few in number. 18, 19) By BLASTn search, we detected the nucleotide sequence of the 1.3-kb DNA in BAC clone RP11-64P12 (AL158066). Also we detected the right-end sequence of YAC clone 923f5 in BAC clone RP11-248G5 (AL139082). Then we constructed a BAC contig map around the YAC clone 923f5 by BLASTn search; the centromere,
When making the contig map, we noticed that the human counterpart (Hmat-5) of the Saccharomyces cerevisiae mannosyltransferase V gene (ALG11) 20) also localized in BAC clone RP11-248G5 (AL139082), right next to the BAC clone RP11-64P12 (AL158066). It would be interesting to determine whether the human counterpart (Hmat-5) of yeast ALG11 and the human gene (Hmat-4) that complements the defect of the G258 mutant is the same. In this context, it is worthy of note that the G258 mutant stops the synthesis of lipid-linked oligosaccharide at Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-P-Dol at 39 C, 3, 6, 7) while the yeast ALG11 gene disruptant can synthesize Man1-2Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-P-Dol but not Man1-2Man1-2Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-P-Dol, making it possible to synthesize a truncated form, Glc 3 Man 8 GlcNAc 2 -P-P-Dol. 20) Hence the yeast ALG11 gene was originally defined as the mannosyltransferase V gene. 20) Although we could not draw any conclusion at the time, we suggested a possible relationship between Hmat-5 and Hmat-4 based on the available data and information, as follows: Case 1-Both the Hmat-4 gene and the Hmat-5 gene are the same gene that is localized in the YAC clone 923f5. The gene product has both mannosyltransferase IV activity and mannosyltransferase V activity. This means that mannosyltransferase V can acts not only on Man1-2Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-P-Dol, but also on Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-P-PDol as a -1,2 mannosyltransferase. Moreover, the Hmat-4/Hmat-5 (Hmat-4/5) gene (mannosyltransferase IV/V gene) can complement the temperature-sensitive defect of the G258 mutant. However, there is a discrepancy between the sizes of the lipid-linked oligosaccharides of the G258 mutant synthesized at 39 C and that of the yeast ALG11 gene disruptant. To clarify this, enzymological or genetic studies are needed. In 2006, Imperiali's group showed that the yeast ALG11 protein has dual functions, and has both mannosyltransferase IV and mannosyltransferase V activities.
2) Thus the G258 mutant might have defects in the expression or enzyme activity of the Mmat-4/5 gene. Complementary DNA-and genomic DNAsequencing studies of the Mmat-4/5 gene of the G258 are in progress. The sequences for forward primer YAC4R and reverse primer 278 are underlined.
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